Brief: Modus Therapeutics Q2 Net Loss Stable At SEK 4.7 Mln
23/08/2024 07:42
Aug 23 (Reuters) - Modus Therapeutics Holding AB MODTX.ST :
* Q2 RESULT AFTER TAX AMOUNTED TO SEK -4,738 (-4,695) THOUSAND.
Source text for Eikon: ID:nMFN9bCDGn
Further company coverage: MODTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Modus Therapeutics Holding AB
See all newsBrief: Modus Therapeutics Temporarily Pauses Enrollment In Phase IIa Study Of Sevuparin In CKD With Anemia
Brief: Modus Gets SEK 0.13 Mln Through Exercise Of Warrants
Brief: Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares
Sweden's Modus Therapeutics narrows Q2 net loss, extends financing
Brief: Modus Therapeutics Q2 Net Income SEK -4.645 Million